Kidney Legislation Currently Before Congress
Below is a list of kidney-related legislation that is before the 113th U.S. Congress. For more information on this legislation please visit www.Congress.gov or contact the AKF Government Relations team at 800.638.8299 extension 7047.
H.R. 4814: Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
To improve care for individuals with chronic kidney disease by addressing gaps in research; improve beneficiary access to treatment; and create economic stability for providers caring for individuals with chronic kidney disease.
More than 31 million Americans are affected by kidney disease. Among those, more than 615,000 Americans are living with kidney failure, also known as end-stage renal disease (ESRD). The only treatment options available for patients with kidney failure are dialysis or a kidney transplant. Individuals with kidney failure frequently have other serious health issues in addition to ESRD. Their lives depend on high-quality care and access to all treatment options. This legislation seeks to improve federal policy related to the care for individuals with chronic kidney disease by addressing gaps in critical research; improve beneficiary access to treatments for chronic kidney disease; and create economic stability for providers caring for individuals with chronic kidney disease.
H.R.4814 introduced 6/9/2014
Learn more about H.R. 4814
S. 323/H.R. 1428: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
To amend title XVIII of the Social Security Act to provide for extended months of Medicare coverage of immunosuppressive drugs for kidney transplant patients and other renal dialysis provisions.
Immunosuppressive drugs are drugs that prevent the body’s immune system from working as it normally would. These drugs are given to transplant patients to prevent the new organ from being rejected. Medicare currently only covers immunosuppressive drugs for non-disabled kidney transplant patients under the age of 65 for 36 months (three years). This legislation would extend Medicare coverage of immunosuppressive drugs for these kidney transplant patients beyond 36 months by allowing kidney transplant patients to enroll in Medicare Part B for the sole purpose of immunosuppressive drug coverage.
S. 323Introduced 2/13/13; H.R. H.R. 1428 Introduced 4/9/13
Learn more about S. 323 /H.R. 1428